AI Holds Promise to Speed Drug Discovery But Verification, Collaboration Needed

AI has potential to accelerate drug discovery but independent verification is needed to confirm benefits.

Some AI drug discovery companies claim faster development but peer review is lacking.

Generative AI can suggest molecules but may propose impossible structures. Feedback loops can help improve.

Academic and industry collaboration is key to validate AI tools for drug discovery.

While AI may speed early stages, clinical trials remain biggest hurdle. Most candidates still fail late stage.